Cerus Corp (CERS)

4.28
0.23 5.70
NASDAQ : Health Care
Prev Close 4.05
Open 4.04
Day Low/High 4.02 / 4.30
52 Wk Low/High 4.27 / 6.89
Volume 1.36M
Avg Volume 819.10K
Exchange NASDAQ
Shares Outstanding 103.47M
Market Cap 428.35M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Cerus Corporation (NASDAQ: CERS) announced today that, on January 3, 2017, the compensation committee of the company's board of directors granted fifteen new non-executive employees options to purchase an...

Relative Strength Alert For Cerus

Relative Strength Alert For Cerus

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of August 2017 Options Trading For Cerus (CERS)

First Week of August 2017 Options Trading For Cerus (CERS)

Investors in Cerus Corp. saw new options become available this week, for the August 2017 expiration.

Cerus Announces Exercise Of Additional BARDA Contract Options Totaling $10,825,555 For Activities Related To Its Planned Phase III Trial Of The INTERCEPT Red Blood Cell System

Cerus Announces Exercise Of Additional BARDA Contract Options Totaling $10,825,555 For Activities Related To Its Planned Phase III Trial Of The INTERCEPT Red Blood Cell System

Cerus Corporation (NASDAQ: CERS) announced today that additional options totaling $10,825,555 have been exercised under its contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the U.

Cerus Provides An Update On The Timeline For The INTERCEPT Blood System For Red Blood Cells In Europe

Cerus Provides An Update On The Timeline For The INTERCEPT Blood System For Red Blood Cells In Europe

Cerus Corporation (NASDAQ:CERS) today provided an update on the timeline for the INTERCEPT Blood System for Red Blood Cells (RBCs) in Europe.

January 2017 Options Now Available For Cerus (CERS)

January 2017 Options Now Available For Cerus (CERS)

Investors in Cerus Corp. saw new options begin trading today, for the January 2017 expiration.

Cerus (CERS) Stock Surges on Q3 Results, Outlook

Cerus (CERS) Stock Surges on Q3 Results, Outlook

Cerus (CERS) reported a narrower-than-expected loss for the 2016 third quarter after yesterday's market close.

Cerus Corporation Reports Third Quarter 2016 Results

Cerus Corporation Reports Third Quarter 2016 Results

Cerus Corporation (NASDAQ: CERS) today announced financial results for the third quarter ended September 30, 2016.

Cerus To Present At The Stephens 2016 Fall Investment Conference On November 8, 2016

Cerus To Present At The Stephens 2016 Fall Investment Conference On November 8, 2016

Cerus Corporation (NASDAQ:CERS) announced today that Kevin Green, Cerus' vice president, finance and chief financial officer, is scheduled to present a corporate update at the Stephens 2016 Fall Investment Conference at...

First Week of December 16th Options Trading For Cerus (CERS)

First Week of December 16th Options Trading For Cerus (CERS)

Investors in Cerus Corp. saw new options become available this week, for the December 16th expiration.

Cerus To Release Third Quarter 2016 Results On November 3, 2016

Cerus To Release Third Quarter 2016 Results On November 3, 2016

Cerus Corporation (NASDAQ:CERS) announced today that its third quarter results will be released on Thursday, November 3, 2016, after the close of the stock market.

Relative Strength Alert For Cerus

Relative Strength Alert For Cerus

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cerus Announces First U.S. Blood Center Customer Submits Biologics License Application To The FDA To Allow For Interstate Export Of INTERCEPT Platelet Components

Cerus Announces First U.S. Blood Center Customer Submits Biologics License Application To The FDA To Allow For Interstate Export Of INTERCEPT Platelet Components

Cerus Corporation (NASDAQ:CERS) announced today that The Community Blood Center (CBC) of Appleton, Wisconsin has submitted the first Biologics License Application (BLA) to the U.

Cerus Announces That Hemolife Fundación Banco Nacional De Sangre Has Entered Into Routine Use Of The INTERCEPT Blood System

Cerus Announces That Hemolife Fundación Banco Nacional De Sangre Has Entered Into Routine Use Of The INTERCEPT Blood System

Cerus Corporation (NASDAQ:CERS), a biomedical products company focused in the field of blood transfusion safety, announced today that Hemolife Fundación Banco Nacional de Sangre (Hemolife) is now offering...

Cerus (CERS) Shares Cross Below 200 DMA

Cerus (CERS) Shares Cross Below 200 DMA

In trading on Thursday, shares of Cerus Corp. crossed below their 200 day moving average of $6.03, changing hands as low as $5.99 per share.

Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Cerus Corporation (NASDAQ:CERS) announced today announced that, on October 1, 2016, the compensation committee of the company's board of directors granted ten new non-executive employees options to purchase an...

First Week of May 2017 Options Trading For Cerus (CERS)

First Week of May 2017 Options Trading For Cerus (CERS)

Investors in Cerus Corp. saw new options begin trading this week, for the May 2017 expiration.

Notable Two Hundred Day Moving Average Cross - CERS

Notable Two Hundred Day Moving Average Cross - CERS

In trading on Monday, shares of Cerus Corp. crossed below their 200 day moving average of $6.01, changing hands as low as $6.00 per share.

Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Cerus Corporation (NASDAQ:CERS) announced today that it has granted stock options and restricted stock units to Vivek K.

Cerus To Present At The Morgan Stanley Global Healthcare Conference On September 14, 2016

Cerus To Present At The Morgan Stanley Global Healthcare Conference On September 14, 2016

Cerus Corporation (NASDAQ:CERS) announced today that William "Obi" Greenman, Cerus' president and chief executive officer, is scheduled to present a corporate update at the Morgan Stanley Healthcare Conference at 1:00PM ET...

Cerus To Present At The Baird 2016 Healthcare Conference On September 8, 2016

Cerus To Present At The Baird 2016 Healthcare Conference On September 8, 2016

Cerus Corporation (NASDAQ:CERS) announced today that Kevin Green, Cerus' vice president, finance and chief financial officer, is scheduled to present a corporate update at the Baird 2016 Healthcare Conference at 12:50PM ET...

FDA's New Recommendation For Universal Zika Risk Reduction Of Blood Components Includes Use Of Pathogen Reduction

FDA's New Recommendation For Universal Zika Risk Reduction Of Blood Components Includes Use Of Pathogen Reduction

Cerus Corporation (NASDAQ: CERS) announced today that the U.S.

October 21st Options Now Available For Cerus (CERS)

October 21st Options Now Available For Cerus (CERS)

Investors in Cerus Corp. saw new options become available today, for the October 21st expiration.

Which Stocks Are Impacted by the Rio Olympics?

Which Stocks Are Impacted by the Rio Olympics?

Wall Street analysts are keeping an eye on the effect of the Rio Olympics on stocks across a variety of sectors, from restaurants to biotech.

Vivek Jayaraman Appointed As Cerus Corporation's Chief Commercial Officer

Vivek Jayaraman Appointed As Cerus Corporation's Chief Commercial Officer

Cerus Corporation (NASDAQ:CERS) announced today the appointment of Vivek Jayaraman as chief commercial officer, effective August 29th, 2016.

Cerus (CERS) Weak On High Volume Today

Cerus (CERS) Weak On High Volume Today

Trade-Ideas LLC identified Cerus (CERS) as a weak on high relative volume candidate

Cerus Corporation Reports Second Quarter 2016 Results

Cerus Corporation Reports Second Quarter 2016 Results

Cerus Corporation (NASDAQ:CERS) today announced financial results for the second quarter ended June 30, 2016.

Cerus To Release Second Quarter 2016 Results On August 4, 2016

Cerus To Release Second Quarter 2016 Results On August 4, 2016

Cerus Corporation (NASDAQ:CERS) announced today that its second quarter results will be released on Thursday, August 4, 2016, after the close of the stock market.